Equibles does not estimate personal net worth.
Chris Geberth is recorded as CFO at Allurion Technologies, Inc. (ALUR). Allurion Technologies, Inc. reported in an 8-K filed August 7, 2023 that Chris Geberth was appointed Chief Financial Officer. Allurion Technologies, Inc. reported in an 8-K filed August 7, 2023 that Chris Geberth was appointed Chief Financial Officer, effective August 1, 2023. Chris Geberth has spoken on 4 earnings calls across 1 company, most recently for Allurion Technologies, Inc. on November 13, 2024. Allurion Technologies, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Allurion Technologies, Inc. includes Krishna Gupta (Chairman and Board Member), Omar Ishrak (Chairman and Board Member), Ojas Buch (COO) and 7 others.
“The Executive shall serve as the Chief Financial Officer of the Company and New Allurion and shall have such powers and duties as may from time to time be prescribed by the Chief Executive Officer of New Allurion (the "CEO").”
“Chris Geberth was appointed as New Allurion's Chief Financial Officer and principal financial officer and principal accounting officer”
“Our revenue for the third quarter of 2024 was $5.4 million compared to $18.2 million for the same period in 2023.”
“Our revenue for the second quarter of 2024 was $11.8 million, marking a sequential increase of $2.3 million, or 25%, from the first quarter of 2024, a decrease of $1.2 million from the second quarter of 2023.”
“First quarter revenue totaled $9.4 million, a decrease of 33% from the first quarter of 2023.”
“Fourth quarter revenue totaled $8.2 million, a decrease of 57% from the fourth quarter of 2022 as we shifted our marketing spend to more efficient channels, sought deeper penetration in key markets, and focused on reducing our channel inventory from earlier in the year.”
Medical Devices · Healthcare
CFO
